References
1. St Hilarie C, Ziegler SG, Markello TC, Brusco A, Groden C, Gill F, et
al. NT5E mutations and arterial calcifications. N Engl J Med
2011;364:432-42.
2. Ichikawa N, Taniguchi A, Kaneko H, Kawamoto M, Sekita C, Nakajima A,
et al. Arterial calcification due to deficiency of CD73 (ACDC) as one of
Rheumatic disease associated with periarticular calcification. J Clin
Rheumatol 2015;21:216-20.
3. Zhang Z, He JW, Fu WZ, Zhang CQ, Zhang ZL. Calcification of joints
and arteries: second report with novel NT5E mutations and expansion of
the phenotype. J Hum Genet 2015;60:561-4.
4. de Nijs T, Albuisson J, Ockeloen CW, Legrand A, Jeunemailtre X,
Schultze Kool LJ,et al. Isolated arterial calcifications of the lower
extremities: A clue for NT5E mutation. Int J Cardiol 2016;212:248-50.
5. Yoshioka K, Kuroda S, Takahashi K, Sasano T, Furukawa T, Matsumura A.
Calcification of joints and arteries with novel NT5E mutations with
involvement of upper extremity arteries. Vasc Med 2017;22:541-43.
6. Kochan Z, Karbowska J, Gogga P, Kutryb-Zajac B, Slominska EM,
Smolenski RT. Polymorphism in exon 6 of the human NT5E gene is
associated with aortic valve calcification. Nucleosides Nucleotides
Nucleic Acids 2016;35:726-731.
7. Zukowska P, Kutryb-Zajac B, Jasztal A, Toczek M, Zabielska M,
Borkowski T, et al. Deletion of CD73 in mice leads to aortic valve
dysfunction. Biochim Biophys Acta Mol Basis Dis 2017;1863:1464-72.
8. Sasaki H, Yanagi K, Ugi S, Kobayashi K, Ohkubo K, Tajiri Y, et al.
Definitive diagnosis of mandibular hypoplasia, deafness, progeroid
features and lipodystrophy (MDPL) syndrome caused by a recurrent de novo
mutation in the POLD1 gene. Endocr J 2018;65:227-38.